Porphyromonas gingivalis lipopolysaccharide: An unusual pattern recognition receptor ligand for the innate host defense system

Acta Odontologica Scandinavica

Volumn 59, Issue 3, 2001, Pages 131-138

  Bainbridge, Brian W ^a   Darveau, Richard P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Inflammation; Innate defense; Lipopolysaccharide; Porphyromonas gingivalis

Indexed keywords

AUTACOID; CELL SURFACE RECEPTOR; DROSOPHILA PROTEIN; IMMUNOGLOBULIN RECEPTOR; LIGAND; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL; CHO CELL; DRUG ANTAGONISM; ENZYME ACTIVATION; ENZYMOLOGY; ESCHERICHIA COLI; GENETIC TRANSFECTION; HAMSTER; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MICROBIOLOGY; MONOCYTE; PERIODONTITIS; PHOSPHORYLATION; PORPHYROMONAS GINGIVALIS; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; CHO CELLS; CRICETINAE; DROSOPHILA PROTEINS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ESCHERICHIA COLI; HUMANS; IMMUNITY, NATURAL; INFLAMMATION MEDIATORS; LIGANDS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIODONTITIS; PHOSPHORYLATION; PORPHYROMONAS GINGIVALIS; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TRANSFECTION;

EID: 0035381253     PISSN: 00016357     EISSN: None     Source Type: Journal    
DOI: 10.1080/000163501750266710     Document Type: Article

References (92)

1. Sorransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 1992;63: 322-31.
2. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67:1123-37.
3. Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996;67:1103-13.
4. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000;14:216-48.
5. Gemmell E, Walsh LJ, Savage NW, Seymour GJ. Adhesion molecule expression in chronic inflammatory periodontal disease tissue. J Periodontal Res 1994;29:46-53.
6. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997;14:112-43.
7. Moughal NA, Adonogianaki E, Thornhill MK, Kinane DF. Endothelial cell leukocyte adhesion molecule-1 (ELAM-1) on endothelial cells in experimental gingivitis in humans. J Periodontol 1992;27:623-30.
8. Nylander K, Danielsen B, Fejerskov O, Dabelsteen E. Expression of the endothelial leukocyte adhesion molecule-1 (ELAM-1) on endothelial cells in experimental gingivitis in humans. J Periodontol 1993;64:355-7.
9. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976;33: 235-49.
10. Tonetti MS. Molecular factors associated with compartmentalization of gingival immune responses and transepithelial neutrophil migration. J Periodontal Res 1997;32:104-9.
11. Tonetti MS, Imboden MA, Gerber L, Lang NP, Laisue J, Mueller C. Localized expression of mRNA for phagocyte-specific hernotactic cytokines in human periodontal infections. Infect Immun 1994;62:4005-14.
12. Moughal NA, Adonogianaki E, Thornhill MH, Kinane DF. Endothelial cell leukocyte adhesion molecule-1 (ELAM-1) and intercellular adhesion molecule-1 (ICAM-1) expression in gingival tissue during health and experimentally-induced gingivitis. J Periodontal Res 1992;27:623-30.
13. Tonetti MS, Imboden MA, Lang NP. Neutrophil migration into the gingival sulcus is associated with transepithelial gradients of interleukin-8 and ICAM-1. J Periodontol 1998;69:1139-47.
14. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14.
15. Hart TC, Shapira L, Van Dyke TE. Neutrophil defects as risk factors for periodontal diseases. J Periodontol 1994;65:521-9.
16. Carrassi A, Abati S, Santarelli G, Vogel G. Periodontitis in a patient with chronic neutropcnia. J Periodontol 1989;60:352-7.
17. Page RC, Beatty P, Waldrop TC. Molecular basis for the functional abnormality in neutrophils from patients with generalized prepubertal periodontitis. J Periodontal Res 1987;22:182-3.
18. Waldrop TC, Anderson DC, Hallmon WW, Schmalstieg FC, Jacobs RL. Periodontal manifestations of the heritable Mac-1, LFA-1, deficiency syndrome. Clinical, histopathologic and molecular characteristics. J Periodontol 1987;58:400-16.
19. Hemmerle J, Frank RM. Bacterial invasion of periodontal tissues after experimental immunosuppression in rats. J Biol Buccale 1991;19:271-82.
20. Attstrom R, Schroeder HE. Effect of experimental neutropenia on initial gingivitis in dogs. ScandJ Dent Res 1979;87:7-23.
21. Sallay K, Listgarten M, Sanavi F, Ring I, Nowotny A. Bacterial invasion of oral tissues of immunosuppressed rats. Infect Immun 1984;43:1091-3.
22. Yoshinari N, Kameyama Y, Aoyama Y, Nishiyama H, Noguchi T. Effect of long-term methotrexate-induced neutropenia on experimental periodontal lesion in rats. J Periodontal Res 1994;29:393-400.
23. Dennison DK, Van Dyke TE. The acute inflammatory response and the role of phagocytic cells in periodontal health and disease. Periodontol 2000 1997;14:54-78.
24. Salvi GE, Lawrence HP, Offenbacher S, Beck JD. Influence of risk factors on the pathogenesis of periodontitis. Periodontol 2000 1997;14:173-201.
25. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1996;1:821-78.
26. Zambon JJ. Periodontal diseases: microbial factors. Ann Periodontol 1996:1:879-925.
27. MacFarlane GD, Herzberg MC, Wolff LF, Hardie NA. Refractory periodontitis associated with abnormal polymorphonuclear leukocyte phagocytosis and cigarette smoking. J Periodontol 1992;63:908-13.
28. Bergstrom J, Persson L, Preber H. Influence of cigarette smoking on vascular reaction during experimental gingivitis. Scand J Dent Res 1988;96:34-9.
29. Darveau RP, Tanner A, Page RC. The microbial challenge in periodontitis. Periodontol 2000 1997;14:12-32.
30. Moore WEC, Moore LVH. The bacteria of periodontal diseases. Periodontol 2000 1994;5:66-77.
31. Marsh PD, Bradshaw DJ. Dental plaque as a biofilm. J Ind Microbiol 1995;15:169-75.
32. Sissons CH, Wong L, Cutress TW. Patterns and rates of growth of microcosm dental plaque biofilms. Oral Microbiol Immunol 1995;10:160-7.
33. Wilson M. Susceptibility of oral bacterial biofilms to antimicrobial agents. J Med Microbiol 1996;44:79-87.
34. Schwartz J, Stinson FL, Parker RB. The passage of tritiated bacterial endotoxin across intact gingival crevicular epithelium. J Periodontol 1972:43:270-6.
35. Hamada S, Takada H, Ogawa T, Fujiwara T, Mihara J. Lipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties. Int Rev Immunol 1990;6:247-61.
36. McCoy SA, Creamer HR, Kawanami M, Adams DF. The concentration of lipopolysaccharide on individual root surfaces at varying times following in vivo root planing. J Periodontol 1987;58:393-9.
37. Moore J, Wilson M, Kieser JB. The distribution of bacterial lipopolysaccharide (endotoxin) in relation to periodontally involved root surfaces. J Clin Periodontol 1986;13:748-51.
38. Wilson M, Moore J, Kieser JB. Identity of limulus amoebocyte lysate-active root surface materials from periodontally involved teeth. J Clin Periodontol 1986;13:743-7.
39. Gemmell E, Marshall RI, Seymour GJ. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontology 2000 1997;14:112-43.
40. Lamster IB. Evaluation of components of gingival crevicular fluid as diagnostic tests. Ann Periodontol 1997;2:123-37.
41. Moskow BS, Polson AM. Histologic studies on the extension of the inflammatoiy infiltrate in human periudontitis. J Clin Periodontol 1991;18:534-42.
42. Roberts FA, Hockett RD Jr, Bucy RP, Michalek SM. Quantitative assessment of inflammatory cytokine gene expression in chronic adult periodontitis. Oral Microbiol Immunol 1997;12:336-44.
43. Offenbacher S, Heasman PA, Collins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-44.
44. McGee JM, Tucci MA, Edmundson TP, Serio CL, Johnson RB. The relationship between concentrations of proinflammatory cytokines within gingiva and the adjacent sulcular depth. J Periodontol 1998;69:865-71.
45. Armstrong RA. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils. Br J Pharmacol 1995;116:2903-8.
46. Garzetti GG, Ciavattini A, Provinciali M, Amati M, Muzzioli M, Governa M. Decrease in peripheral blood polymorphonuclear leukocyte chemotactic index in endometriosis: role of prostaglandin E2 release. Obstet Gynecol 1998;91:25-9.
47. Janeway CA Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992;13:11-6.
48. Nauts HC, Fowler GA, Bogatko FH. A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man. Acta Med Scand 1953;Suppl 276.
49. Shear MJ, Turner FC, Perrault A, Shovelton T. Chemical treatment of tumors. V. Isolation of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrate. J Nat Cancer Inst 1943;4:81-97.
50. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-70.
51. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992;176:1665-71.
52. Pugin J, Heumann D, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, et al. CD14 is a pattern recognition receptor. Immunity 1994;1:509-16.
53. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, et al. Structure and function of lipopolysaccharide binding protein. Science 1990;249:1429-33.
54. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-3.
55. Pugin J, Schurer-Maly C-C, Leturcq D, Moriarty A, Ulevitchr J, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993;90: 2744-8.
56. Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995;270: 10842-8.
57. Wright SD. CD14 and innate recognition of bacteria. J Immunol 1995;155:6-8.
58. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996;4:407-14.
59. Leturcq DJ, Moriarty AM, Talbott G, Winn RK, Martin TR, Ulevitch RJ. Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest 1996;98:1533-8.
60. Delude RL, Savedra R Jr, Zhao H, Thieringer R, Yamamoto S, Fenton MJ et al. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc Natl Acad Sci USA 1995;92:9288-92.
61. Kitchens RL, Munford RS. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biol Chem 1995;270:9904-10.
62. Chaudhary PM, Ferguson C, Nguyen V, Nguyen O, Massa HF, Eby M, et al. Cloning and characterization of two Toll/ Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans. Blood 1998;91:4020-7.
63. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity [see comments]. Nature 1997;388:394-7.
64. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998;95:588-93.
65. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999;274:10689-92.
66. Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 1998;188:2091-7.
67. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling [see comments]. Nature 1998;395:284-8.
68. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996:86:973-83.
69. Williams MJ, Rodriguez A, Kimbrell DA, Eldon ED. The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J 1997;16:6120-30.
70. Poltorak A, Ricciardi-Castagnoli P, Citterio S, Beutler B. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci U S A 2000;97:2163-7.
71. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999;163:1-5.
72. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000; 105:497-504.
73. Bambridge BW, Darveau RP. Lipopolysaccharide from oral bacteria: role in innate host defense and chronic inflammatory disease. In: Morrison D, editor. Endotoxin in health and disease. New York: Marcel Dekker; 1997. p. 899-913.
74. Shapira L, Takashiba S, Amar S, Van Dyke TE. Porphyromonas gingivalis lipopolysaccharide stimulation of human monocytes: dependence on serum and CD14 receptor. Oral Microbiol Immunol 1994:9:112-7.
75. Ogawa T, Uchida H. Differential induction of IL-1 beta and IL-6 production by the nontoxic lipid A from Porphyromonas gingivalis in comparison with synthetic Escherichia coli lipid A in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 1996;14:1-13.
76. Darveau RP, Cunningham MD, Bailey T, Seachord C, Ratcliffe K, Bainbridge B, et al. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect Immun 1995;63:1311-7.
77. Tanamoto K, Azumi S, Haishima Y, Kumada H, Umemoto T. Endotoxic properties of free lipid A from Porphyromonas gingivalis. Microbiology 1997;143:63-71.
78. Lindermann RA, Economou JS. Actinobacillus actinomycetemcomitans and Bacteroides gingivalis activate human peripheral monocytes to produce interleukin-1 and tumor necrosis factor. J Periodontol 1988;59:728-30.
79. Agarwal S, Piesco NP, Johns LP, Riccelli AE. Differential expression of IL-1 beta, TNF-alpha, IL-6, and IL-8 in human monocytes in response to lipopolysaccharides from different microbes. J Dent Res 1995;74:1057-65.
80. Roberts FA, Richardson GJ, Michalek SM. Effects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes. Infect Immun 1997;65:3248-54.
81. Bainbridge BW, Page RC, Darveau RP. Immunization of Macaca fascicularis with Porphyromonas gingivalis elicits an ability to neutralize LPS induced production of PGE2 by mononuclear cells. Infect Immun 1997;65:4801-5.
82. Cunningham MD, Seachord C, Ratcliffe K, Bainbridge B, Aruffo A, Darveau RP. Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14. Infect Immun 1996;64:3601-8.
83. Beamer LJ, Carroll SF, Eisenberg D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 1997;276:1861-4.
84. Yu B, Wright SD. Catalytic properties of lipopolysaccharide (LPS) binding protein. J Biol Chem 1996;271:4100-5.
85. Cunningham MD, Shapiro RA, Seachord C, Ratcliffe K, Cassiano L, Darveau RP. CD14 employs hydrophilic regions to 'capture' lipopolysaccharides. J Immunol 2000;164:3255-63.
86. Hanazawa S, Nakada K, Ohmori Y, Miyoshi T, Amano S, Kitano S. Functional role of interleukin 1 in periodontal disease: induction of interleukin 1 production by Bacteroides gingivalis lipopolysaccharide in peritoneal macrophages from C3H/HeN and C3H/HeJ mice. Infect Immun 1985;50:262-70.
87. Takada H, Hirai H, Fujiwara T, Koga T, Ogawa T, Hamada S. Bacteroides lipopolysaccharides (LPS) induce anaphylactoid and lethal reactions in LPS-responsive and -nonresponsive mice primed with muramyl dipeptide. J Infect Dis 1990;162;428-34.
88. Tanamoto K, Azumi S, Haishima Y, Kumada H, Umemoto. The lipid A moiety of Porphyromonas gingivalis lipopolysaccharide specifically mediates the activation of C3H/HeJ mice. J Immunol 1997;158:4430-36.
89. Faure E, Equils O, Siding PA, Thomas L, Zhang FX, Kirschning CJ, et al. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothclial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 2000;275:11058-63.
90. Darveau RP, Belton CM, Reife RA, Lamont RJ. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun 1998;66:1660-5.
91. Yoshimura A, Hara Y, Kaneko T, Kato I. Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. J Periodontal Res 1997;32:279-86.
92. Reife RA, Shapiro RA, Bamber BA, Berry KK, Mick GE, Darveau RP. Porphyromonas gingivalis lipopolysaccharide is poorly recognized by molecular components of innate host defense in a mouse model of early inflammation. Infect Immun 1995;63; 4686-94.